Jörg Ellinger

33PUBLICATIONS
101CO-AUTHORS
Molecular targetsComputational linguisticsPredictive and prognostic markersCancer diagnosisLearning, motivation and emotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Dec 20, 2024
The New Tumour Biomarker miRNA-371-3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell Lines.

Richard Weiten, Theadora Engler, Hubert Schorle

|May 16, 2024
Urology consultants versus large language models: Potentials and hazards for medical advice in urology.

Johanna Eckrich, Jörg Ellinger, Alexander Cox

|May 16, 2024
Bellmunt risk score as a survival predictor in patients with metastatic castration-resistant prostate cancer.

Thomas Büttner, Niklas Klümper, Richard Weiten

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Mar 20, 2024
Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.

Thomas Büttner, Florian Gärtner, Markus Essler

|Feb 10, 2024
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.

Thomas Büttner, Dimo Dietrich, Romina Zarbl

Pageof 6

Frequent Collaborators

10 joint publications

Niklas Klümper

8 joint publications

Philipp Krausewitz

5 joint publications

Thomas Büttner

3 joint publications

Glen Kristiansen